Cresco Labs Inc.
CRLBF
$0.90
-$0.05-5.22%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -6.33% | -2.04% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.33% | -2.04% | |||
| Cost of Revenue | -3.01% | -8.56% | |||
| Gross Profit | -9.45% | 4.99% | |||
| SG&A Expenses | -1.78% | 12.89% | |||
| Depreciation & Amortization | -0.95% | -11.89% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.42% | -0.75% | |||
| Operating Income | -37.67% | -11.23% | |||
| Income Before Tax | 96.79% | -762.76% | |||
| Income Tax Expenses | 689.12% | -84.82% | |||
| Earnings from Continuing Operations | 80.87% | -304.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 189.64% | -72.30% | |||
| Net Income | 85.08% | -413.59% | |||
| EBIT | -37.67% | -11.23% | |||
| EBITDA | -18.46% | -13.21% | |||
| EPS Basic | 85.25% | -407.08% | |||
| Normalized Basic EPS | -64.12% | -46.03% | |||
| EPS Diluted | 85.25% | -407.08% | |||
| Normalized Diluted EPS | -64.12% | -46.03% | |||
| Average Basic Shares Outstanding | 1.20% | 1.22% | |||
| Average Diluted Shares Outstanding | 1.20% | 1.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||